25/04/2026
Malaria continues to be a significant public health challenge, especially across low and middle income countries.
Expanding access to effective treatment remains critical. Since 2013, Strides has supplied 2.4 billion doses of anti-malarial treatment, reaching patients across more than 60 countries worldwide.
Through continued focus on access, innovation, and collaboration, the effort remains centred on improving outcomes where it is needed most.